These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21512174)

  • 21. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical-diffusion mismatch predicts the putative penumbra with high specificity.
    Prosser J; Butcher K; Allport L; Parsons M; MacGregor L; Desmond P; Tress B; Davis S
    Stroke; 2005 Aug; 36(8):1700-4. PubMed ID: 16020762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mismatch definition.
    Nagakane Y; Christensen S; Ogata T; Churilov L; Ma H; Parsons MW; Desmond PM; Levi CR; Butcher KS; Davis SM; Donnan GA;
    Stroke; 2012 Jun; 43(6):1548-55. PubMed ID: 22499579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion.
    Lansberg MG; Thijs VN; Bammer R; Olivot JM; Marks MP; Wechsler LR; Kemp S; Albers GW
    Stroke; 2008 Sep; 39(9):2491-6. PubMed ID: 18635861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study.
    Lansberg MG; Lee J; Christensen S; Straka M; De Silva DA; Mlynash M; Campbell BC; Bammer R; Olivot JM; Desmond P; Davis SM; Donnan GA; Albers GW
    Stroke; 2011 Jun; 42(6):1608-14. PubMed ID: 21493916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying thresholds for penumbra and irreversible tissue damage.
    Heiss WD; Sobesky J; Hesselmann V
    Stroke; 2004 Nov; 35(11 Suppl 1):2671-4. PubMed ID: 15459433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set.
    Mlynash M; Lansberg MG; De Silva DA; Lee J; Christensen S; Straka M; Campbell BC; Bammer R; Olivot JM; Desmond P; Donnan GA; Davis SM; Albers GW;
    Stroke; 2011 May; 42(5):1270-5. PubMed ID: 21474799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes.
    Kane I; Carpenter T; Chappell F; Rivers C; Armitage P; Sandercock P; Wardlaw J
    Stroke; 2007 Dec; 38(12):3158-64. PubMed ID: 17975106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent.
    Campbell BC; Purushotham A; Christensen S; Desmond PM; Nagakane Y; Parsons MW; Lansberg MG; Mlynash M; Straka M; De Silva DA; Olivot JM; Bammer R; Albers GW; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):50-6. PubMed ID: 21772309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.
    Cho TH; Hermier M; Alawneh JA; Ritzenthaler T; Desestret V; Østergaard L; Derex L; Baron JC; Nighoghossian N
    Stroke; 2009 Oct; 40(10):3400-2. PubMed ID: 19696413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.
    Wheeler HM; Mlynash M; Inoue M; Tipirnini A; Liggins J; Bammer R; Lansberg MG; Kemp S; Zaharchuk G; Straka M; Albers GW;
    Int J Stroke; 2015 Jul; 10(5):723-9. PubMed ID: 25580662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: usefulness of magnetic resonance angiography-diffusion mismatch.
    Dembo T; Deguchi I; Fukuoka T; Nagoya H; Maruyama H; Kato Y; Horiuchi Y; Ohe Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1056-63. PubMed ID: 22902147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
    Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.
    Simonsen CZ; Madsen MH; Schmitz ML; Mikkelsen IK; Fisher M; Andersen G
    Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA.
    Wu TC; Sitton C; Potter A; Bowry R; Sahota P; Cai C; Hui P; Chen Z; Gonzales N; Barreto A; Lopez G; Grotta JC; Savitz SI
    J Neurol Sci; 2014 May; 340(1-2):165-9. PubMed ID: 24694764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study.
    Asdaghi N; Hill MD; Coulter JI; Butcher KS; Modi J; Qazi A; Goyal M; Demchuk AM; Coutts SB
    Stroke; 2013 Sep; 44(9):2486-92. PubMed ID: 23908062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliability of assessing percentage of diffusion-perfusion mismatch.
    Coutts SB; Simon JE; Tomanek AI; Barber PA; Chan J; Hudon ME; Mitchell JR; Frayne R; Eliasziw M; Buchan AM; Demchuk AM
    Stroke; 2003 Jul; 34(7):1681-3. PubMed ID: 12805485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.